Advertisement

---

SECOND GENOME, INC.

Second Genome Announces Agreement with Janssen on Microbiome Drug Discovery in Ulcerative Colitis

[2013-06-05] - The role of gut bacteria in ulcerative colitis to be the focus of pharmaceutical collaboration in microbiome R&D
In a separate announcement, Second Genome completes third tranche of $11.5 Million Series A financing and expands board of directors and scientific advisors


Advertisement
Most read: scientific news

More:

---


---
Follow us...

google plus Facebook twitter Newsletter

---


---

Plan du site

Actualités

Actualités

Actualités

Réglementaire

Emploi

Annuaires

Dictionnaire

Divers